Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$18.09 USD
-0.28 (-1.52%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $18.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.86 |
EPS Last Quarter | -1.02 |
Last EPS Surprise | 0.00% |
ABR | 1.18 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.11 |
Next Year | -4.64 |
EPS (TTM) | -3.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 31.93M | 31.95M | 247.88M | 105.22M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 34.20M | 34.30M | 252.50M | 156.88M |
Low Estimate | 30.00M | 30.00M | 244.00M | 30.00M |
Year ago Sales | 32.00M | 31.00M | 117.00M | 247.88M |
Year over Year Growth Est. | -0.23% | 3.06% | 111.86% | -57.55% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.86 | -1.11 | -3.11 | -4.64 |
# of Estimates | 5 | 4 | 6 | 5 |
Most Recent Consensus | -0.86 | -0.87 | -3.54 | -3.69 |
High Estimate | 0.07 | -0.87 | -2.47 | -3.19 |
Low Estimate | -1.38 | -1.40 | -3.90 | -6.73 |
Year ago EPS | -0.94 | -1.08 | -4.15 | -3.11 |
Year over Year Growth Est. | 8.51% | -2.78% | 25.06% | -49.13% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.86 | -1.11 | -3.11 | -4.64 |
7 Days Ago | -0.86 | -1.11 | -3.11 | -4.64 |
30 Days Ago | -0.86 | -1.11 | -3.03 | -4.64 |
60 Days Ago | -0.86 | -1.19 | -3.09 | -4.38 |
90 Days Ago | -0.63 | -0.95 | -3.07 | -3.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.86 | -1.11 | -3.54 | -4.64 |
Zacks Consensus Estimate | -0.86 | -1.11 | -3.11 | -4.64 |
Earnings ESP | 0.00% | 0.00% | -13.83% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.02 | -0.05 | -1.08 | -0.94 | NA |
Estimate | -1.02 | -0.97 | -1.09 | -1.12 | NA |
Difference | 0.00 | 0.92 | 0.01 | 0.18 | 0.28 |
Surprise | 0.00% | 94.85% | 0.92% | 16.07% | 27.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more